WaferGen Files for $40M Public Offering; Seeks Move to Nasdaq | GenomeWeb

NEW YORK (GenomeWeb) – WaferGen Biosystems has filed with regulators to offer up to $40 million of its common stock.

In its Form S-1 filed recently with the US Securities and Exchange Commission, the company also said that it has applied with the Nasdaq to list its common shares on the Nasdaq Capital Market under ticker symbol "WGBS." The company said that it expects the Nasdaq listing to occur upon consummation of the $40 million offering. WaferGen currently lists its stock on the OTCQB Marketplace.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.